Participations à des congrès et colloques internationaux (104)
  1. 80. Bouchat, S., Delacourt, N., Kula, A., Darcis, G., Corazza, F., Gatot, J.-S., Melard, A., Vanhulle, C., Van Driessche, B., Kabeya, K., Pardons, M., Avettand-Fenoel, V., Clumeck, N., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2016). Sequential Treatment with 5-aza-2’deoxycitidin and Desacetylase Inhibitors Reactivates HIV-1. Paper session presented at ANRS AC32 (2016: Paris, France).
  2. 81. Darcis, G., Bouchat, S., Kula, A., Van Driessche, B., Delacourt, N., Vanhulle, C., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2016). Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir. Poster présenté à la conférence BREACH (2016: Charleroi, Belgium).
  3. 82. Fauquenoy, S., Kula, A., Delacourt, N., Vanhulle, C., Le Douce, V., Schwartz, C., Van Driessche, B., Gautier, V., Rohr, O., & Van Lint, C. (2016). Role of post-translational modification of CTIP2 in transcriptional regulation of HIV-1 and HTLV-1. Paper session presented at Annual EU4HIVCURE Symposium (2016: Dublin, Ireland).
  4. 83. Fauquenoy, S., Van Driessche, B., Rodari, A., Kula, A., Delacourt, N., Vanhulle, C., Schwartz, C., Gautier, V., Burny, A., Rohr, O., & Van Lint, C. (2016). Epigenetic and transcriptional regulation of HTLV-1/BLV gene expression. Paper session presented at Télévie Cancer Seminar 2017 (2016: Brussels, Belgium).
  5. 84. Rodari, A., Van Driessche, B., Delacourt, N., Vanhulle, C., Galais, M., Fauquenoy, S., Burny, A., Van Den Broeke, A., Rohr, O., & Van Lint, C. (2016). Epigenetic and transcriptional characterization of RNAPII- and RNAPIII-dependent new promoters in the Bovine Leukemia Virus (BLV). Paper session presented at Matinées de Microbiologie Moléculaire (21-22 Janvier 2016: Gosselies, Belgium).
  6. 85. Van Lint, C. (2015). Molecular mechanisms of HIV-1 postintegration latency: implications for therapeutic strategies. Paper session presented at 2015 Keystone Symposia on “Mechanisms of HIV persistence: Implications for a Cure” (April 26-May 1st, 2015: Boston, USA).
  7. 86. Van Driessche, B., Rodari, A., Delacourt, N., Vanhulle, C., & Van Lint, C. (2015). Study of RNA polymerase II-mediated and RNA polymerase III-mediated transcriptions of Bovine Leukemia Virus (BLV). Paper session presented at 1st Molecular Microbiology Mornings (Gosselies, Belgium).
  8. 87. Bouchat, S., Delacourt, N., Kula, A., Darcis, G., Corazza, F., Gatot, J.-S., Melard, A., Vanhulle, C., Van Driessche, B., Kabeya, K., Pardons, M., Avettand-Fenoel, V., Clumeck, N., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2015). Sequential Treatment with 5-aza-2’deoxycitidin and Desacetylase Inhibitors Reactivates HIV-1. Poster présenté à la conférence BELVIR (Brussels, Belgium).
  9. 88. Fauquenoy, S., Van Driessche, B., & Van Lint, C. (2015). Role of Sp1 and CTIP2 in the transcriptional regulation of HTLV-1. Poster présenté à la conférence Annual Télévie Seminar (2015: Gembloux, Belgium).
  10. 89. Fauquenoy, S., Robette, G., Kula, A., Delacourt, N., Vanhulle, C., Burny, A., Van Driessche, B., & Van Lint, C. (2015). Role of Sp1 and CTIP2 in the transcriptional regulation of Human T-Lymphotropic Virus-1. Paper session presented at Third Annual Meeting of The Belgian Society for Virology (2015: Brussels, Belgium).
  11. 90. Rodari, A., Van Driessche, B., Delacourt, N., Vanhulle, C., Galais, M., Fauquenoy, S., Burny, A., Van Den Broeke, A., Rohr, O., & Van Lint, C. (2015). In vivo characterization of the RNAPIII-dependent BLV mirRNA cluster. Paper session presented at BELVIR Third annual meeting (December 18, 2015: Brussels, Belgium).
  12. 91. Van Lint, C. (2014). What is latency and what are its determinates ? Paper session presented at the 20th Internatinal AIDS Conference (AIDS 2014) (July 20-25, 2014: Melbourne, Australia).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>